{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-193424","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2023-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.286884+00:00","generated_at":"2026-06-13T03:17:59.434295+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aligos shareholders elect three Class III directors and ratify Ernst & Young as auditor at 2023 Annual Meeting","bullets":["Jack B. Nielsen (20,201,692 For), Bridget Martell (24,022,757 For), and Carole Nuechterlein (21,653,372 For) elected as Class III directors with 9,713,860 broker non-votes.","Ernst & Young ratified as independent auditor for FY2023: 34,670,204 For, 11,096 Against, 918 Abstain.","As of record date May 23, 2023, 40,410,244 shares were outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-193424","json":"https://secwatch.observer/filing/0001193125-23-193424.json","markdown":"https://secwatch.observer/filing/0001193125-23-193424.md","text":"https://secwatch.observer/filing/0001193125-23-193424.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523193424/0001193125-23-193424-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523193424/d428056d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T03:17:59.434295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3331fdcaaa213af97fd0ba0cb198aa550a53c6fb","claim":"Aligos Therapeutics, Inc. shareholders approved Ratification of the selection by the audit committee of the board of directors of the Company of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. at the 2023-07-20 meeting.","evidence_excerpt":"Proposal 2 . The ratification of the selection by the audit committee of the board of directors of the Company of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. The results of the vote were as follows: Votes For Votes Against Abstentions 34,670,204 11,096 918","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523193424/0001193125-23-193424-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-20"}],"fact_type":"shareholder_vote"},{"claim_id":"6a55a21033423d8173605c4787f71d257663a2de","claim":"Aligos Therapeutics, Inc. shareholders approved Election of three Class III directors to hold office until the 2026 annual meeting of stockholders or until their respective successor is elected. at the 2023-07-20 meeting.","evidence_excerpt":"Proposal 1 . The election of three Class III directors to hold office until the 2026 annual meeting of stockholders or until their respective successor is elected. The results of the vote were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Jack B. Nielsen 20,201,692 4,766,666 9,713,860 Bridget Martell, M.A., M.D. 24,022,757 945,601 9,713,860 Carole Nuechterlein, J.D. 21,653,372 3,314,986 9,713,860","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523193424/0001193125-23-193424-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}